Related Experiment Video
Updated: Jul 17, 2026
08:26
Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
New agents in development for breast cancer.
1Institute of Materia Medica, KangHong Pharmaceutical Goup, Chengdu, People's Republic of China. gxplww2003@yahoo.com.cn
Current Opinion in Obstetrics & Gynecology
|January 16, 2007
Summary
This review highlights effective breast cancer therapies, including targeted treatments like epidermal growth factor receptor inhibitors and endocrine therapies. New dual inhibitors show promise for overcoming treatment resistance and improving outcomes.
Area of Science:
- Oncology
- Pharmacology
Background:
- Growth factor receptor overexpression is common in breast cancer.
- Targeting these receptors is a key therapeutic strategy.
Purpose of the Study:
- To review current therapeutic drugs for breast cancer.
- To discuss new agents under development.
Main Methods:
- Literature review of therapeutic agents for breast cancer.
- Analysis of targeted therapies and endocrine treatments.
Main Results:
- Epidermal growth factor receptor (EGFR), insulin-like growth factor receptor (IGFR), and vascular endothelial growth factor receptor (VEGFR) are key targets.
- Trastuzumab, pertuzumab, gefitinib, and erlotinib are approved agents.
- Selective estrogen receptor modulators (SERMs) and aromatase inhibitors are valuable in endocrine therapy, especially for postmenopausal women with advanced breast cancer.
Conclusions:
- Approved EGFR-targeted inhibitors, SERMs, and aromatase inhibitors remain valuable.
- Developing new dual inhibitors is crucial to overcome resistance and enhance efficacy.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...